8 studies found for:    Open Studies | "Norovirus"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
Condition: Norovirus
Interventions: Biological: Norovirus GI.1/GII.4 Bivalent VLP Vaccine;   Drug: 0.9% sodium chloride (saline)
2 Recruiting Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis Norovirus
Interventions: Biological: Norovirus GII.2 Challenge;   Other: Placebo
3 Recruiting Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Children
Condition: Norovirus
Interventions: Biological: GI.1/GII.4 (15/15) - MPL (50);   Biological: GI.1/GII.4 (15/50) - MPL (50);   Biological: GI.1/GII.4 (50/50) - MPL (50);   Biological: GI.1/GII.4 (15/15) - MPL (15);   Biological: GI.1/GII.4 (15/50) - MPL (15);   Biological: GI.1/GII.4 (50/50) - MPL (15);   Biological: GI.1/GII.4 (15/15);   Biological: GI.1/GII.4 (15/50);   Biological: GI.1/GII.4 (50/50);   Biological: GI.1/GII.4 (50/150);   Biological: GI.1/GII.4 (15/50) - Al(OH)3 (167);   Drug: Placebo
4 Recruiting Human Breastmilk in Young Children With Norovirus Infection of the Gut
Condition: Norovirus Infections
Intervention: Biological: Donor Breastmilk
5 Recruiting A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Condition: Acute Gastroenteritis
Intervention:
6 Not yet recruiting Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
Condition: Healthy Volunteers
Interventions: Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine;   Biological: NoV vaccine placebo
7 Recruiting NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
Condition: Advanced Refractory Solid Tumors
Intervention: Drug: NOV120401
8 Recruiting Viral Infections in Healthy and Immunocompromised Hosts
Condition: Herpes Viruses
Intervention:

Indicates status has not been verified in more than two years